Gastrodin ameliorates anxiety-like behaviors and inhibits IL-1beta level and p38 MAPK phosphorylation of hippocampus in the rat model of posttraumatic stress disorder
Language English Country Czech Republic Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
24020812
DOI
10.33549/physiolres.932507
PII: 932507
Knihovny.cz E-resources
- MeSH
- Anti-Anxiety Agents administration & dosage pharmacology MeSH
- Administration, Oral MeSH
- Benzyl Alcohols administration & dosage pharmacology MeSH
- Time Factors MeSH
- Behavior, Animal drug effects MeSH
- Phosphorylation MeSH
- Glucosides administration & dosage pharmacology MeSH
- Hippocampus drug effects enzymology MeSH
- Interleukin-1beta metabolism MeSH
- Interleukin-6 metabolism MeSH
- Rats MeSH
- Drugs, Chinese Herbal administration & dosage pharmacology MeSH
- p38 Mitogen-Activated Protein Kinases metabolism MeSH
- Disease Models, Animal MeSH
- Motor Activity drug effects MeSH
- Stress Disorders, Post-Traumatic drug therapy enzymology psychology MeSH
- Rats, Sprague-Dawley MeSH
- Nitric Oxide Synthase Type II metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Anti-Anxiety Agents MeSH
- Benzyl Alcohols MeSH
- gastrodin MeSH Browser
- Glucosides MeSH
- Interleukin-1beta MeSH
- Interleukin-6 MeSH
- Drugs, Chinese Herbal MeSH
- p38 Mitogen-Activated Protein Kinases MeSH
- Nos2 protein, rat MeSH Browser
- Nitric Oxide Synthase Type II MeSH
Gastrodin, a main constituent of a Chinese herbal medicine, has been shown to be effective in treating various mood disorders. The purpose of the present study was to determine whether gastrodin could ameliorate stress-associated behavior in a rat model of enhanced single prolonged stress (ESPS)-induced posttraumatic stress disorder (PTSD). Following ESPS, rats were administered orally with gastrodin (50, 100, or 200 mg/kg daily) or vehicle for 2 weeks. Animals were then tested in the open field and elevated plus-maze, and the levels of IL-6 and IL-1beta, the expression of iNOS, p38 and phospho-p38 (p-p38) in hippocampus were also tested. ESPS exposure resulted in pronounced anxiety-like behavior, elevated IL-6 and IL-1beta levels, and the higher expression of iNOS and p-p38 in hippocampus. However, repeated treatment with gastrodin, particularly at higher doses, reversed the aforementioned changes, including anxiety-like behavior, levels of IL-6 and IL-1beta, and the expression of iNOS and the p38 MAPK phosphorylation. These results indicate that gastrodin possesses anxiolytic effect and may be an effective herbal preparation for the treatment of PTSD.
References provided by Crossref.org